Menu Search
Equities

Craneware PLC

3X6:BER

Craneware PLC

Actions
  • Price (EUR)26.00
  • Today's Change-0.600 / -2.26%
  • Shares traded0.00
  • 1 Year change+98.47%
  • Beta--
Data delayed at least 15 minutes, as of Apr 26 2024 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Craneware plc is a United Kingdom company that is engaged in the development, licensing, and ongoing support of computer software for the United States healthcare industry. Its value cycle insights are delivered through its Trisus platform for revenue integrity and 340B management, as well as margin and operational intelligence. Its applications and team of experts contextualize operational, financial, and clinical data, providing insights that clearly demonstrate realistic revenue integrity and 340B compliance opportunities for its customers. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Healthcare Intelligence, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Sentrex 330, Referral Verification System (Sentrex), Referral Verification System (Senturion), Sentry Core, Senturion Professional Service and others.

  • Revenue in GBP (TTM)144.30m
  • Net income in GBP7.48m
  • Incorporated1999
  • Employees734.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.